Traws Pharma Statistics

Total Valuation

Traws Pharma has a market cap or net worth of $9.29 million. The enterprise value is -$6.64 million.

Market Cap	9.29M
Enterprise Value	-6.64M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Traws Pharma has 5.56 million shares outstanding. The number of shares has increased by 266.94% in one year.

Current Share Class	5.56M
Shares Outstanding	5.56M
Shares Change (YoY)	+266.94%
Shares Change (QoQ)	+134.30%
Owned by Insiders (%)	6.59%
Owned by Institutions (%)	6.74%
Float	3.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	22.69
Forward PS	50.61
PB Ratio	1.55
P/TBV Ratio	1.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.81

Current Ratio	1.81
Quick Ratio	1.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -2,331.25% and return on invested capital (ROIC) is -259.06%.

Return on Equity (ROE)	-2,331.25%
Return on Assets (ROA)	-83.59%
Return on Invested Capital (ROIC)	-259.06%
Return on Capital Employed (ROCE)	-287.47%
Revenue Per Employee	$32,429
Profits Per Employee	-$4.94M
Employee Count	7
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.48% in the last 52 weeks. The beta is 1.47, so Traws Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.47
52-Week Price Change	-85.48%
50-Day Moving Average	1.55
200-Day Moving Average	4.58
Relative Strength Index (RSI)	52.52
Average Volume (20 Days)	3,412,747

Short Selling Information

The latest short interest is 95,720, so 1.72% of the outstanding shares have been sold short.

Short Interest	95,720
Short Previous Month	74,699
Short % of Shares Out	1.72%
Short % of Float	2.54%
Short Ratio (days to cover)	0.55

Income Statement

In the last 12 months, Traws Pharma had revenue of $227,000 and -$34.61 million in losses. Loss per share was -$11.22.

Revenue	227,000
Gross Profit	227,000
Operating Income	-24.90M
Pretax Income	-18.16M
Net Income	-34.61M
EBITDA	-24.89M
EBIT	-24.90M
Loss Per Share	-$11.22

Full Income Statement

Balance Sheet

The company has $15.94 million in cash and n/a in debt, giving a net cash position of $15.94 million or $2.86 per share.

Cash & Cash Equivalents	15.94M
Total Debt	n/a
Net Cash	15.94M
Net Cash Per Share	$2.86
Equity (Book Value)	6.00M
Book Value Per Share	1.08
Working Capital	8.46M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-30.81M
Capital Expenditures	n/a
Free Cash Flow	-30.81M
FCF Per Share	-$5.54

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-10,969.60%
Pretax Margin	-61,696.04%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Traws Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-266.94%
Shareholder Yield	-266.94%
Earnings Yield	-372.43%
FCF Yield	-331.51%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 23, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Sep 23, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

Traws Pharma has an Altman Z-Score of -49.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-49.17
Piotroski F-Score	2